Table 1

Cohort characteristics for patients who met inclusion criteria

StudyNAgeASCVD event incidence*% censoredNAgeASCVD event incidence*% censored
Black womenBlack men
ARIC181253.25.70%6.51121653.89.61%10.03
CARDIA23243.04.42%8.1915342.71.63%14.38
CHS30470.722.52%15.4618170.530.89%27.62
JHS131051.42.77%14.9675151.14.47%14.11
MESA76860.35.18%9.6463060.97.19%13.17
All442654.65.69%10.26293155.18.15%13.07
 Non-Black womenNon-Black men
ARIC481553.92.54%3.30438354.57.17%4.86
CARDIA28942.70.39%6.2333342.50.90%6.91
CHS184870.720.18%15.58116971.032.00%17.45
FHS OS82846.42.61%1.8185647.18.67%3.86
MESA191360.53.81%7.68182860.86.67%10.07
All969357.45.95%6.47856956.910.36%7.67
 All
All25 61956.57.54%8.28

  • Data are grouped by sex and race, as well as data set. Each group of patients is described by four values: total number of individuals, mean age, censoring-adjusted incidence of ASCVD events within 10 years of the initial examination and fraction of censored individuals.

  • *ASCVD event incidence was calculated by weighing the number of positive outcome and negative outcome uncensored individuals with the sum of their inverse probability of censoring weights.

  • ARIC, Atherosclerosis Risk in Communities Study; ASCVD, atherosclerotic cardiovascular disease; AUROC, area under the receiver operating characteristic; CARDIA, Coronary Artery Risk Development in Young Adults Study; CHS, Cardiovascular Health Study; FHS OS, Framingham Heart Study Offspring Cohort; FNR, false negative rate; FPR, false positive rate; IPCW, inverse probability of censoring; JHS, Jackson Heart Study; MESA, Multi-Ethnic Study of Atherosclerosis; PCE, Pooled Cohort Equations.